Group’s ideas to change EU pricing rules draw captive audience.
The risky business of outmaneuvering Europe’s drug pricing authorities.
Fresh round of discussions around health technology assessment.
Efforts for a standardized approach coming to a head in Europe.
European Commission looks to relieve issues without legislation.
Looks to address disconnect between registration and reimbursement.